• Blog
  • Reviews
  • Contact US
    Sign in Sign up
    • Psychiatry Education Forum Academy
    • PEFA Network
    • Blog
    • Reviews
    • Dashboard
    • Contact Us

    Tag: Alzheimer’s Disease

    First Weekly Transdermal Patch Approved for Alzheimer’s Dementia: ADLARITY

    On March 14, 2022: FDA has approved the first and only once-weekly transdermal patch for Alzheimer’s dementia: Adlarity (Donepezil). Psychiatry Education Forum Academy has summarized…

    Dr. Harvinder Singh March 19, 2022

    How to Evaluate Six Neurocognitive Domains in Dementia? [PUBLISHED]

    Psychiatry Education Forum Academy published its next discussion series today: It is important to have knowledge of these six neuro-cognitive domains for the evaluation &…

    Dr. Harvinder Singh July 24, 2021

    Alzheimer’s Disease: Comparing FDA Approved Medications

    Alzheimer’s disease is the most common type/cause of dementia. As we know that FDA recently approved Aducanumab (Aduhelm) for the treatment of Alzheimer’s Disease (read…

    Dr. Harvinder Singh June 28, 2021

    Aducanumab: New Medication FDA Approved for Alzheimer’s Disease

    June 07, 2021 Today FDA has approved Aducanumab (Aduhelm) for the treatment of Alzheimer’s Disease. This is the first novel treatment to target the underlying…

    Dr. Harvinder Singh June 7, 2021

    Join Academy Membership

    Most Recent Posts

    • Anti-NMDAR Encephalitis: What should you know as a Psychiatrist? March 9, 2023
    • Transdermal Asenapine March 5, 2023
    • Managing Bipolar Disorder in Elderly February 25, 2023
    • Serotonin Syndrome February 19, 2023
    • Antipsychotics Induced Nocturnal Enuresis February 18, 2023
    • Psycho-Ophthalmology: Psychotropics Ocular Adverse Events February 11, 2023
    • Integrative and Complementary Psychiatry February 5, 2023
    • Hydroxychloroquine & Psychotropics Interaction February 3, 2023
    • Amazon RxPass: $5/month Generics January 30, 2023
    • MDD Augmentation: Low Dose Naltrexone January 29, 2023
    • MDD Augmentation: S-Adenosyl Methionine (SAMe) January 28, 2023
    • MDD Augmentation: Pramipexole January 26, 2023
    • MDD Augmentation: Buspirone January 22, 2023

    Please note that this website is for educational purposes only and do refer to sources cited at the end of each topics for more information. Psychiatry Education Forum and authors do not assume any liability or responsibility for damage, injury, or death to you, other persons or property from any use of any ideas, information, or instruction in this website.

    Psychiatry Education Forum
    © 2023 - Psychiatry Education Forum   DISCLAIMER: Please note that this website is for educational purposes only and do refer to sources cited at the end of each topic for more information. Psychiatry Education Forum and authors do not assume any liability or responsibility for damage, injury, or death to you, other persons, or property from any use of any ideas, information, or instruction in this website.

    Report

    There was a problem reporting this post.

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Contains spam, fake content or potential malware

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • See blocked member's posts
    • Mention this member in posts
    • Invite this member to groups
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

    Report

    You have already reported this .